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Membrane locationOlive oil has been recognized to possess many therapeutic applications. Its beneﬁcial effects arise from many
causes, but one of them lies on the presence of oleuropein aglycone (OA). OA presents a plethora of pharmaco-
logical beneﬁcial properties. Although there is a great research going on the effect of polyphenols and their deriv-
atives on different aspects of health, much less knowledge is available of the molecular basis of their beneﬁcial
effects. Due to the prominent hydrophobic character of OA and its high phospholipid/water partition coefﬁcient,
some of its possible effects on biological systems might be related to its capacity to interact with and locate into
the membrane. In this work we have aimed to locate the molecule of OA in two membrane model systems,
i.e., POPC/Chol and POPC/POPG/Chol. OA locates in between the hydrocarbon acyl chains of the phospholipids
but its speciﬁc location andmolecular interactions differ depending on the lipid system.OA is nearer to themem-
brane surface in the POPC/Chol system but it is located at a deeper position in the POPC/POPG/Chol system. Fur-
thermore, OA seems to interact stronger with POPG than with POPC, implying the existence of speciﬁc
interactionswith negatively-charged phospholipids. Some of the biological effects of OA could be due to its pref-
erential location in themembrane depending on themembrane lipid composition aswell as the existence of spe-
ciﬁc interactions with speciﬁc phospholipids.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Virgin olive oil contains a large amount of triacylglycerols as well as
small quantities of other compounds such as fatty acids, phenols, pig-
ments, sterols, tocopherols and many others [1,2]. The pharmacological
properties of olive oil have been recognized to possessmany therapeutic
applications giving place to a healthy diet known as the Mediterranean
diet [3]. The beneﬁcial effects of the Mediterranean diet arises from
many causes, and one of them lies on the increased contents of polyphe-
nols and secoiridoids present in different food complements, including
olive oil but also green tea and red wine. Phenols are found in all parts
of the olive plant and oleuropein (OLE), a secoiridoid, together with its
aglycone derivative, oleuropein aglycone (OA), is the most abundant
polyphenols in Oleaceae, in particular Olea Europaea and represent the
main phenolic oleosides found in virgin olive oil [1,3–6]. OLE and OA
present a plethora of pharmacological beneﬁcial properties, such as an-
tioxidant, anti-inﬂammatory, anti-atherogenic, skin-protectant, anti-one; OLE, oleuropein; POPC, 1-
PG, 1-palmitoyl-2-oleoyl-sn-
lecular y Celular, Universitascancer, antimicrobial and antiviral effects as well as having cardio- and
neuro-protective roles [1,3,4,7–17]. Consequently, many experimental,
clinical and epidemiological studies suggest that the consumption of
phenolic-enriched foods reduces many chronical diseases [18,19].
Recently it has been shown that oleuropein aglycone (OA) presents an-
ticancer activity related to the activation of anti-aging/cellular stress-
like gene signatures, suppress epithelial-to-mesenchymal transition sig-
naling cascade and suppress genes involved in the Warburg effect as
well as protect against Alzheimer-associated neurodegeneration [3,6,8,
10,11,20,21]. Interestingly, OA is more effective than OLE as an inhibitor
of Tau ﬁbrillization [22]. Although there is a great research ongoing on
the effect of polyphenols and their derivatives on different aspects of
health, much less knowledge is available of the molecular and cellular
basis of their beneﬁcial effects. These beneﬁcial phenolic molecules can
be envisaged more as nutraceuticals than drugs. Much information is
needed in order to use them, not only from the biochemical and clinical
point of view but also on their location and the speciﬁc interactions they
might possess with other biomolecules.
OLE is an ester of 2-(3,4-dihydroxyphenyl)ethanol (hydroxytyrosol)
and the glucosidic form of elenolic acid and some of its effects, similarly
to othermolecules, have been ascribed to its capacity to interactwith bi-
ological membranes [1]. However, different studies have indicated that
OLE locates either at a superﬁcial position in the membrane or at its in-
ternal part, depending on membrane lipid composition [23–25]. Its
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ments of the plant or by intestinal bacteria gives rise to OA [26,27], a
molecule that is more hydrophobic than OLE. The presence of the
methoxycarbonyl group in OA favors its cyclic hemiacetalic form
(Fig. 1) due to the conjugation of the ester group with the internal dou-
ble bond [20]. Due to theprominent hydrophobic character of OA and its
high phospholipid/water partition coefﬁcient, some of its possible ef-
fects on biological systems might be related to its capacity to interact
with and locate into the palisade structure of the membrane [25,28].
However, it should be taken into account that the partition coefﬁcient
of a molecule estimates its lipophilicity but does not give any clue
about its location and orientation in the membrane. Furthermore, the
interaction of the molecule with the membrane and its location inside
it might change its physical properties and therefore modulate the in-
teraction of the membranes with other biological molecules, which
could account for its biological activities.
In this work we aim to discern the location and orientation of OA
inserted in model membranes by atomistic molecular dynamics (MD).
MD is a very useful methodology to probe the dynamics, interaction,
structure and location of phospholipids in biological model membranes
as well as different types of molecules inserted in them [29]. The fact
that OA mode of action is most likely through membrane interaction,
it seems reasonable to think that its mode of action might be at least
partly attributable to its speciﬁc effect on the membrane structure, its
speciﬁc interactions with particular lipid molecules and, last but not
least, its location inside the membrane. For that goal, we have used
two different types of model membranes, one composed of the zwitter-
ionic phospholipid phosphatidylcholine (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine, POPC) and the other one containing both
the zwitterionic phospholipid, POPC, and the negatively-charged
phosphatidylglycerol (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
(1′-rac-glycerol), POPG). Our results support a superﬁcial location of
OA in the membrane and the existence of speciﬁc interactions withFig. 1.Molecular structures of the hemiacetalic cyclic form of oleuropein aglycone (OA), 1-palm
3-phospho-(1′-rac-glycerol) (POPG). Numbering of particular atoms mentioned in the text is aspeciﬁc phospholipids that could explain, at least in part, some of its bi-
ological effects.
2. Methods
2.1. Molecular dynamics simulation
Unrestrained all-atommolecular dynamics simulationswere carried
out using NAMD 2.9 [30] utilizing the CHARMM36 force ﬁeld for the
lipidmolecules [31] and the CHARMMgeneral forceﬁeld for OA [32] ob-
tained from http://mackerell.umaryland.edu/charmm_ff.shtml. The
TIP3P model was used for water [33]. All simulations were carried out
with a constant number of particles as an NPT ensemble at 1.0 atm
and 310 K. The time step was 2 fs. Constant pressure was maintained
by the Nosé–Hoover Langevin pistonmethod [34,35]. Constant temper-
aturewasmaintained by Langevin dynamicswith a damping coefﬁcient
γ of 0.5 ps−1. The standard particle mesh Ewald method was used with
periodic boundary conditions to calculate the long-range electrostatic
interaction of the systems. Non-bonded interactions were cut off after
12 Å with a smoothing function applied after 10 Å [36]. Prior to simula-
tion and in order to remove unfavorable atomic contacts, themembrane
model systems were previously equilibrated for 1 ns after 50,000 steps
of minimization. The production trajectory of the lipid systemswas cal-
culated for 150 ns. All simulations were conducted under electrostati-
cally neutral environment with an appropriate number of sodium ions.
2.2. Bilayer membrane model
We have used two different lipid bilayer models, one of them com-
posed of POPC/Chol at a molar ratio of 7:1 and the other one composed
of POPC/POPG/Chol at amolar ratio of 5:2:1. Eachmodel comprised 128
lipid molecules (64 lipids in each leaﬂet) in a rectangular box. The
POPC/Chol system was comprised by 16 molecules of cholesterol anditoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-
lso given.
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(POPC) surrounded by 5780 molecules of water. The POPC/POPG/Chol
system was comprised by 16 molecules of cholesterol, 80 molecules of
POPC and 32 molecules of POPG surrounded by 5560 molecules of
water. The phospholipid/cholesterol ratio chosen represents 12.5% of
cholesterol in the sample. Cholesterol is an indispensable molecule for
the organization and organization of the membrane and modiﬁes the
physico-chemical properties of the lipid bilayer. However, there are
many different phospholipid/cholesterol ratios found in biological
membranes, from less than 5% (ER, mitochondria) to more than 40%
(erythrocyte), so that we have taken a compromise. In this way, the
cholesterol content we have used does not affect largely the simulation
time scale but better simulates a model biomembrane. The solvent-to-
lipid ratio was ~45 for the POPC/Chol and ~43 for the POPC/POPG/
Chol one, i.e., excesswater [37]. Fig. 1 presents the structures and carbon
numbering of the molecules considered in this study, OA, POPC and
POPG. The bilayer lied in the xy plane and the bilayer normal was paral-
lel to the z-axis. Initially the simulation box had the dimensions of
8.9 nm in the x- and y-directions and 8 nm in the z-direction. The height
of the simulation box and the cross sectional area was allowed to vary
independently of each other. Each water layer had an average dimen-
sion of 5.4 Å betweenmembranes due to periodic boundary conditions.
OA was generated and minimized using Discovery Studio 4.0 software
(Accelrys Inc., SanDiego, USA). As it is well known, phosphatidylcholine
is the dominant lipid species in biological membranes, cholesterol is
omnipresent inmany types ofmembranes giving themunique biophys-
ical properties and phosphatidylglycerol provides negative charge at the
membrane surface [38]. Since we have used POPC and POPG, the
palmitoyl chain located in the sn-1 position is completely saturated,
whereas the oleoyl chain located in the sn-2 position contains a cis dou-
ble bond between the C9 and C10 carbons (see Fig. 1 for acyl chain num-
bering). The presence of the oleoyl chain in the sn-2 position increases
the overall mobility of the hydrocarbon chains of the phospholipids
andhenceﬂuidity in the xyplane of themembrane. The lipidmembrane
models, including POPC, POPG, cholesterol andOA,were prepared using
the Charmm-Gui web server (http://www.charmm-gui.org, [39]).
ParamChem (https://cgenff.paramchem.org, [32]) was used to obtain
the CHARMM General Force Field (CGenFF) compatible stream ﬁle of
OA which contained the optimized parameter and topology data of
the molecule (for the optimization guide see http://mackerell.
umaryland.edu/~kenno/cgenff/). The automatic PSF generation plugin
for VMD [40] utilized the OA stream ﬁle data to obtain the psf and pdb
ﬁles of OA required by NAMD to build the complete system. Since OA
has a highly hydrophobic character, a high phospholipid/water partition
coefﬁcient and it is known to insert into themembrane, at the beginning
of the simulation the OA molecule was embedded at the center of the
lipid bilayer in order to quickly reach convergence This conﬁguration
was speciﬁcally chosen so that the simulation did not extend excessive-
ly in the time scale [41].
2.3. Analysis
The surface of the membrane was deﬁned by the layer of the phos-
phate atoms of the phospholipid headgroups andwere oriented parallel
to the xy plane. Bilayer thickness was deﬁned as the average distance
between the phospholipid phosphorus atoms of the opposing leaﬂets,
whereas the center of the bilayer, z = 0, was deﬁned by the center-of-
mass of the phosphate atoms of the phospholipid molecules. The center
of mass z-distance of the OAmolecule relative to the center of the bilay-
er was used to study its spatial distribution in the membrane. The OA
membrane relative orientation was measured by the angle deﬁned by
the z-axis and the vector deﬁned by carbons C4 and C4′ of themolecule
of OA (see Fig. 1 for numbering). The analysis was performed over the
whole MD simulation unless stated otherwise. VMD [40] and Pymol
[42] were used for visualization and analysis. SCD order parameters,
membrane thickness, molecular areas, center-of-mass and moleculetilt were obtained using VMD Membplugin [43] whereas the mass
density proﬁles were obtained using the VMD Density Proﬁle Tool
plugin [44].
3. Results and discussion
As an indicator of the equilibration of the bilayer we have used the
time variation of the area per lipid and to assess the adequacy of the
simulation methodology we have obtained its average value [45,46].
The time traces of the area per molecule, i.e., POPC, POPG, cholesterol
and OA, corresponding to the z+ and z− leaﬂets for the system
POPC/Chol are shown in Fig. 2A and B, respectively, whereas those cor-
responding to the z+ and z− leaﬂets for the system POPC/POPG/Chol
are shown in Fig. 2C and D, respectively. As expected, no signiﬁcant
changes were found in the general bilayer properties in these diluted
systems, i.e., systems having only one molecule of OA. The data show
that for both systems studied in this work, POPC/Chol and POPC/
POPG/Chol, phospholipids and cholesterol were equilibrated early on
the course of the simulations, either at the z+ or at the z− bilayer leaf-
lets, indicating that the systems reached a steady state after 10 ns of
simulation. At the end of the simulation, the mean area of POPC and
Chol was 59–60 A2 and 39–36 A2, respectively, in both membrane sys-
tems whereas it was 59 A2 for POPG in the POPC/POPG/Chol system,
in agreementwith previously reported data [47]. However, the behavior
of the molecular area of OA was different from those of the phospho-
lipids and cholesterol. In theﬁrst place, theOAmolecular area presented
a great variation along the whole simulation time in both membrane
systems (compare the area variation of OA with that of the phospho-
lipids, Fig. 4A and C). This is due to the structure of the OA molecule
and its location and disposition in the membrane (see below). In the
secondplace, theOAmolecular areawas equilibratedwith its surround-
ings at about 10 ns for the system POPC/POPG/Chol (Fig. 2C) but for the
system POPC/Chol the OAmolecular area was equilibrated with its sur-
roundings much later, i.e., at about 115 ns (see Fig. 2A). The inserts in
Fig. 2A and C show the area histograms for OA for the last 5 ps of the
simulation for the systems POPC/Chol and POPC/POPG/Chol, respective-
ly. It can be observed that themean area for OA in the POPC/Chol system
is about 100 A2 whereas is about 85 A2 in the POPC/POPG/Chol system.
In a similarly way to the behavior of the area vs. time trend commented
above,membrane thickness, measured as the average distance between
the phosphate atoms of opposite leaﬂets, was held relatively constant
after 13 and 10 ns for the systems POPC/Chol and POPC/POPG/Chol,
respectively, indicating again a rapid equilibration of both systems
(Fig. 2E and F).
The initial and ﬁnal conﬁgurations for both POPC/Chol and POPC/
POPG/Chol membrane model systems are shown in Fig. 3. As
commented above and at the start of the simulation, the OA molecule
was located in the middle of the palisade structure of the bilayer at
the same coordinates for both systems (Fig. 3A and B for POPC/Chol
and POPC/POPG/Chol systems, respectively). At the end of the simula-
tion OA locates near the surface in vicinity to the phospholipid
headgroups for the POPC/Chol system (Fig. 3C). However, in the
POPC/POPG/Chol system OA, although moves slightly towards the
membrane interface, remains buried in between the hydrocarbon
chains of the phospholipids of the z+ leaﬂet (Fig. 3D). It is clear from
this pictures that OA locates below the phospholipid headgroups but
relatively far from the bilayer center.
This behavior is clearly observed in the time variation of the center-
of-mass of OA for both membrane model systems (Fig. 4A and B for the
systems containing POPC/Chol and POPC/POPG/Chol, respectively). For
the system POPC/Chol and at about 25 ns, OA equilibrates in a position
which remains relatively similar to that found at the end of the simula-
tion, i.e., 150 ns (Fig. 4A). The time needed by OA to reach the equilibri-
um position in the POPC/POPG/Chol system is similar, being also about
25 ns, remaining in that position until the end of the simulation
(Fig. 4B). However, the difference in ﬁnal location in both systems is
Fig. 2. Time variation of the (A–D)molecular areas of each species in the z+ (A, C) and z− (B, D) leaﬂets of the bilayer and (E, F)membrane thickness formembranemodel systems com-
posed of (A, B, E) POPC/Chol/OA and (C, D, F) POPC/POPG/Chol/OA. In plots A–Dblack, green, red, and blue stand for POPC, POPG, Chol andOA, respectively. Inserts in (A) and (B) show the
area histograms for OA for the last 5 ps in each membrane system.
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cation of OA in the POPC/Chol system is about 17.5 Å, the ﬁnal average
relative location of OA in the POPC/POPG/Chol system is about 6.8 Å. It
is important to note also the great deviation in OA location, since for
the last 1 ns the location of OA in the POPC/Chol system oscillates be-
tween 15 and 19 Å whereas in the POPC/POPG/Chol system oscillates
between 5.5 and 9 Å (Fig. 4A and B).
Mass density proﬁleswere calculated for all components of both sys-
tems studied in this work, POPC/Chol (Fig. 4C) and POPC/POPG/Chol
(Fig. 4D). As observed in Fig. 4C, OA lies on average at a depth slightly
lower than the phosphate groups of both phospholipids, POPC and
POPG, at the same level as theOHgroup of cholesterol. This is in contrastto the location of OA in the POPC/POPG/Chol system, since its location is
similar to that of the cholesterol tail (approximately between atoms C21
and C27 of cholesterol) as observed in Fig. 4D. It is interesting to note
that the density proﬁle of the phosphate atoms located in the z+ leaﬂet
in the POPC/POPG/Chol system is rather asymmetric when compared to
the density proﬁle of the phosphate atoms located in the z− leaﬂet
(Fig. 4D). This data would imply the existence of at least two different
populations of phosphate atoms regarding to their relative location in
the membrane.
Fig. 4E shows the mass density proﬁle of the phosphate atoms of
POPC and POPG phospholipids in the POPC/POPG/Chol system where
it can be observed the existence of subtle but signiﬁcant differences.
Fig. 3. Initial (t= 0) andﬁnal (t= 150 ps) snapshots of (A, C) POPC/Chol and (B, D) POPC/POPG/Cholmembranemodel systems. The phospholipid andwatermolecules are shown in light
blue and red, respectively. The OA molecule and the phosphate atoms are depicted in VDW drawing style.
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in the z− leaﬂet are 20.8 and 20.5 Å, respectively, but the maxima for
the phosphate atoms of POPC and POPG in the z+ leaﬂet are 21.9 and
20.1 Å, respectively. The difference in the maxima is therefore 0.3 and
0.8 Å for the z− and the z+ leaﬂets, respectively, whichwould indicate
that the positioning of the phosphate atoms of POPC and POPG are dif-
ferent in the membrane, being lower for the phosphate atoms of POPG
than those of POPC. Furthermore, signiﬁcant differences can be ob-
served for the half bandwidth of the density proﬁles in both leaﬂets.
The half bandwidth of the density proﬁle corresponding to the POPC
phosphate atoms in the z− leaﬂet is 5.5 Å whereas it is 4.9 Å for the
phosphate atoms of POPG. In the case of the z+ leaﬂet, the half band-
width of the density proﬁle corresponding to the POPC phosphate
atoms is 7 Åwhereas it is 7.3 Å for the phosphate atoms of POPG. There-
fore, the density proﬁles corresponding to the phosphate atoms of both
phospholipid types are broader in the z+ leaﬂet than in the z− one,
going from 5.5 to 7 Å in the case of the phosphate atoms of POPC
(a difference of 1.5 Å) and from 4.9 to 7.3 in the case of the phosphate
atoms of POPG (a difference of 2.4 Å). This data would imply that OA
affects to a higher extend the molecules of POPG than those of POPC
(see below).
The orientation of OA in themembrane was studied considering the
angle formedby themolecular axis deﬁned by the vector joiningOA car-
bons 4 and 4′with the bilayer normal (Fig. 5A and B for the POPC/Chol
and POPC/POPG/Chol systems, respectively). As observed in Fig. 5A,
which corresponds to OA in the POPC/Chol system, there was a greatvariation in angle along the simulation time, ranging from a minimum
value of about 5° at the beginning of the simulation time and a maxi-
mum one of 176° in the middle. At the end of the simulation, the varia-
tion was much lower, with an average angle of about 95° with a
deviation of ± 15° (Fig. 5A, insert). For the system POPC/POPG/Chol,
the deviation at the beginning of the simulation was much higher
than in themiddle and end of it as observed in Fig. 5B. The values ranged
from a minimum value of about 14° and a maximum of 166°. The gen-
eral variation was much lower than that observed for OA in the
POPC/Chol system. At the end of the simulation, the average angle was
about 80° having a deviation of ± 10° (Fig. 5B, insert).We have also an-
alyzed the distance between carbons4 and4′ of OAalong the simulation
and the data is represented in Fig. 5C and D for the systems POPC/Chol
and POPC/POPG/Chol, respectively. Similarly to the angle variation
commented above, the distance between carbons 4 and 4′ varied
greatly along the simulation time. For OA in POPC/Chol the values
ranged from 4.9 Å to 9.8 Å (Fig. 5C), whereas for OA in POPC/POPG/
Chol the values ranged from 3.7 Å to 10.2 Å (Fig. 5D). At the
end of the simulation, the average distance was 8.8 Å for OA in
POPC/Chol and 8.3 Å in POPC/POPG/Chol. Fig. 5E and F show the ﬁnal
structures of OA in the POPC/Chol and POPC/POPG/Chol systems, re-
spectively. It can be observed that their disposition in the membrane
is not completely different, since as commented above, the difference
in the angles are about 15°; however, their overall conformation is dif-
ferent, at least if we compare the relative disposition of the rings in
the molecule.
Fig. 4. Time variation of the OA center-of-mass for the membrane systems containing (A) POPC/Chol and (B) POPC/POPG/Chol, respectively. The average center-of-mass of OA, the z+
leaﬂet phosphate atoms and the z+ and z− leaﬂets phosphate atoms are visible. Mass density proﬁles for the last 1 ns of the simulation for OA (−−, multiplied by 10), water (····),
POPC and POPG (−··−··, POPG multiplied by 2), cholesterol (—, multiplied by 3) and phospholipid phosphate atoms (−·−·, multiplied by 3) for the (C) POPC/Chol and (D) POPC/
POPG/Chol (B, D) systems. The enlargement of the mass density proﬁle of the phosphate groups of POPC (−−) and POPG (—, multiplied by 2) for the POPC/POPG/Chol system is
shown in (E).
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tion of OA in both model membrane systems, POPC/Chol and POPC/
POPG/Chol. However, membrane order is affected by OA and we have
investigated the effect of the presence of the molecule of OA on the
nearest phospholipid acyl chains. As noted above, OA barely affects
membrane thickness and slightly the average location of POPC andPOPG phosphate atoms. However, membrane order is evident in the
deuterium order parameter −SCD of the hydrocarbon acyl chains of
the phospholipids. −SCD can vary between 0.5, i.e., full order along
the normal bilayer, and −0.25, i.e., full order along the bilayer plane
[48]. When−SCD is equal to 0 it indicates isotropic orientation. There-
fore, we have calculated the −SCD values for both saturated and
Fig. 5. Time variation of the angle deﬁned by the vector joining carbons 4–4′ of OA and the membrane z axis (A, B) and time variation of the distance between carbons 4 and 4′ of OA
(C, D) for the POPC/Chol (A, C) and POPC/POPG/Chol (B, D) systems. The inserts show the histograms of the angle and distance variation for the last 2 ns of the simulation. The ﬁnal struc-
tures of OA in (E) POPC/Chol and (F) POPC/POPG/Chol are shown. Dotted lines represent CH/OH bonds.
2855V. Galiano, J. Villalaín / Biochimica et Biophysica Acta 1848 (2015) 2849–2858unsaturated acyl chains of POPC and POPG in both model membrane
systems and the results are shown in Fig. 6. The average−SCD values
for the sn-1 and sn-2 acyl chains of POPC for the POPC/Chol system in
both leaﬂets, z+ and z−, are relatively similar (Fig. 4A and B, respec-
tively), in agreementwith the proﬁles observed earlier for experimental
and simulated data [31,49,50]. However, it should be taken into account
that there are 56 molecules of POPC and 8 molecules of cholesterol per
leaﬂet in the system but only one molecule of OA (see above). Because
of that, we have calculated the −SCD values of the POPC molecules
that are within 7 Å of the molecule of OA as shown in Fig. 6A and B for
the sn-1 and sn-2 acyl chains, respectively. It is evident from the ﬁguresthat the presence of OA gives place to small but signiﬁcant effects on
carbons 4–12 of the acyl chains of POPC. They can be understood by not-
ing that OA has two rings in a relatively rigid structure, the molecule
does not completely span the leaﬂet of the bilayer and its location is co-
incidental with carbons 4–12 of the acyl chains (see Fig. 4).
The average−SCD values for the sn-1 acyl chains of POPC and POPG
in the POPC/POPG/Chol system are shown in Fig. 4C and E, respectively,
whereas the average−SCD values for the sn-2 acyl chains of POPC and
POPG are shown in Fig. 4D and F, respectively. Although the POPC/
POPG/Chol system has one molecule of OA plus 40 molecules of POPC,
16 molecules of POPG and 8 molecules of Chol in each leaﬂet, there
Fig. 6. Deuterium order parameter−SCD calculated for the sn-1 (A, C, E) and sn-2 (B, D, F) acyl chains of POPC (A–D) and POPG (E, F) for the membrane model systems composed of
(A, B) POPC/Chol and (C–F) POPC/POPG/Chol. The average−SCD parameters for the z+ (-■-) and z− (-□-) bilayer leaﬂets and the−SCD parameters for the lipid acyl chains within
7 Å of the molecule of OA (▲) are shown. The analysis was carried out for the last 1 ns of simulation.
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These differences might reﬂect the long range effects of the speciﬁc lo-
cation of OA in themembrane. More interesting is the differential effect
observed for both the sn-1 and sn-2 chains of those molecules of POPC
and POPG near OA. OA decreases the −SCD values of all carbons
pertaining to the acyl sn-1 chains of both POPC and POPG near it, but
the effect is signiﬁcantly higher for POPG than for POPC (compare
Fig. 6C and D). The effect is different but more noteworthy when the
−SCD values pertaining to the sn-2 chains of POPC and POPG are com-
pared (Fig. 6D and F). The presence of OA lowered the−SCD values of
the carbons 2–7 pertaining to the sn-2 chain of POPC but no effect was
visible on the other ones (Fig. 6D). The effect was more dramatic for
the sn-2 chain of POPG when compared to the average −SCD values,
since OA lowered the−SCD values of all carbons of the sn-2 acyl chain
of POPG except carbons 10 and 11 (Fig. 6F). More interestingly, the
−SCD values of carbons 8, 9 and 12 were negative (−0.14,−0.23 and−0.014, respectively) whereas the−SCD values of carbons 10 and 11
were 0.26 and 0.17, respectively. These data would imply that OA re-
duced the acyl chain order parameter of the sn-2 acyl chain of POPG
but locally increased the order parameter of the unsaturated carbons
of the phospholipid.
4. Conclusions
A number of literature studies have suggested that oleuropein agly-
con (OA) resides in the membrane and its mode of action might be at-
tributable to its effect on the membrane as a whole and/or speciﬁc
lipid molecules inserted in them. However, a deﬁnite assessment of its
location is still lacking. This work aimed to locate the molecule of
oleuropein aglycon (OA) in the membrane and discern, if possible, the
speciﬁc interactions of themoleculewithmembrane lipids usingmolec-
ular dynamics simulations. For that aim, we have used two membrane
2857V. Galiano, J. Villalaín / Biochimica et Biophysica Acta 1848 (2015) 2849–2858model systems, i.e., POPC/Chol and POPC/POPG/Chol. Although there is
the evident limitation of simulating a single molecule inserted in the
membrane, our simulation provides a detailed clue on the nature of in-
teractions and location of OA in themembrane.Moreover, we have used
a simulation time of 150 ns, which should be enough to permit the
equilibration of all the molecules of the systems and therefore obtain
meaningful conclusions about them. One of the main conclusion we
can obtain from this study is that OA locates in between the hydrocar-
bon acyl chains of the phospholipids. However, its speciﬁc location
and molecular interactions differ depending on the lipid system. In the
POPC/Chol system, OA is nearer to the membrane surface than to the
middle of the palisade structure of the membrane; on the contrary, OA
tends to be located in a deeper position, nearer to the center of the
membrane in the POPC/POPG/Chol system. This difference in OA loca-
tion depending on membrane system is reinforced by the effect of OA
in the order parameters of the phospholipids, which is stronger on
POPG than on POPC. These data would suggest the existence of speciﬁc
interactions with negatively-charged phospholipids rather than zwit-
terionic ones. Finally, and regarding the biological activity of OA, it
should be noted that it tends to be preferentially located in a speciﬁc lo-
cation in the membrane where its spatial concentration should be
higher than inferred from the speciﬁc OA contents in available foods,
whereby increasing its in vivo biological activities.
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